Altemus, M, Dale, J K, Michelson, D et al. · Psychoneuroendocrinology · 2001 · DOI
This study tested how the bodies of ME/CFS patients respond to a hormone called vasopressin. Researchers compared 19 patients with ME/CFS to 19 healthy volunteers by giving them vasopressin infusions and measuring hormone levels in their blood. ME/CFS patients showed a weaker response in a key stress hormone called ACTH, suggesting their brain may not be producing enough of another hormone called CRH that helps control stress responses.
This study provides mechanistic evidence that ME/CFS involves a specific neuroendocrine abnormality in the brain's stress hormone system, rather than being purely psychological. Understanding this dysfunction could lead to targeted treatments and validates the biological basis of the condition. The findings help explain why ME/CFS patients experience persistent fatigue despite appearing physically well.
This study does not prove that reduced CRH is the sole cause of ME/CFS fatigue, only that it is associated with the condition. The study uses an indirect measure of CRH (vasopressin-stimulated ACTH response) rather than directly measuring CRH levels. It does not establish whether this neuroendocrine abnormality is a primary cause, consequence, or contributing factor to ME/CFS development.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.